KefiBIOS is the first Lactobacillus Kefiri LKF01 (DSM 32079) LKEF-based probiotic isolated from kefir.
Kefir is a millennia-old acidic drink made from milk or water and obtained by fermentation with lactic acid bacteria.
In the early 1900s, Mechnikov, the Nobel Prize in Medicine, highlighted the correlation between the longevity of the rural population of the Caucasus and their diet, mainly based on the consumption of kefir. Mechnikov developed a theory according to which the aging process is associated with the activity of proteolytic microbes. They are part of the normal human gut microbiota that produce toxic substances (such as phenols, indoles, and ammonia) through protein digestion and are responsible for what he called “intestinal autointoxication.” Because lactic acid bacteria inhibited the growth of proteolytic bacteria, Mechnikov suggested introducing them into the daily diet for health benefits.
How to use KefiBIOS correctly
When using it for the first time, it is necessary to dissolve the powder contained in the special capsule inside the vial, paying particular attention to keeping the capsule upright during the opening. Shake well before use and before any subsequent use. The drops should be taken directly or mixed with cold food or drinks at room temperature or warm, provided they do not exceed 37°C. The possible presence of undissolved particles after mixing is a natural characteristic of the product and is therefore not a defect.
Can it also be used by those who are lactose intolerant?
Because it is derived from water kefir granules, KefiBIOS can also be used by those who are lactose intolerant, those on a vegan diet, and those with celiac disease.
I had the opportunity to get acquainted with some of the research carried out during the development of KefiBIOS.
Among them, of course, high adhesion to intestinal cells should be singled out; in fact, the L.Kefiri LKF01 (DSM 32079) LKEF strain showed a very strong and noticeable adhesion to the epithelium of over 80% compared to other bacterial strains tested.
Clinical evaluation conducted for the analysis of the colonization of the intestine also showed positive results. In fact, one month after the introduction of the strain L.Kefiri LKF01 (DSM 32079) LKEF, the microorganism was found in the feces of all subjects participating in the study. The study demonstrated the high colonizing ability of the L.Kefiri LKF01 (DSM 32079) LKEF strain, which not only survives in the gastric environment but is also able to persist and be viable in the human intestine.